Blog Read the latest perspectives from our team of subject matter experts and others Drug Development Predictions 2026The drug development landscape is undergoing rapid transformation. After a year of significant policy changes, regulatory updates, and technology maturation, 2026 will be a defining year for how clinical… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Artificial IntelligenceKOL EngagementAI and the MSL Evolution: What Time Has Taught UsI recently had the chance to deliver the keynote address at the 2022 MSL Society Conference in Las Vegas. It’s been a transformative year for pharma and life sciences, specifically… Continue reading → Read the article CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataTimmy Awards Announces H1 as 2022 Tech for Good FinalistThe 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is… Continue reading → Read the article KOL EngagementGoing with the Digital FlowEven now: two and a half years later, the COVID-19 pandemic continues to have a substantial impact on the activities of Medical Science Liaisons (MSLs), including access to Key… Continue reading → Read the article Drug DevelopmentPatient RepresentationThe ABCs (and Ds) of Clinical Trial InclusionWhen the FDA mandated guidelines earlier this year for broader clinical trial inclusion, it brought a long-standing challenge in pharma and life sciences into the spotlight. Here, Alexandra Moens, H1’s… Continue reading → Read the articleno Drug DevelopmentKOL EngagementPatient RepresentationA New Reflection on Pharma, Research, and Patient CarePharma has long existed in elevated, prestigious academic institutions: ivory towers of reputable and revered centers of excellence famous for disseminating the latest in clinical research and medical breakthroughs.… Continue reading → Read the article Drug DevelopmentKOL EngagementH1 Announces Partnership with Society for Clinical Research SitesThe Society for Clinical Research Sites (SCRS) announced today that H1, a pioneer in creating connected ecosystems where data, people, research, and clinical trial intelligence come together to drive the… Continue reading → Read the article«‹78910111213›»
